Related Experiment Video
Updated: May 5, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Evaluation of microvascular reactivity with laser Doppler flowmetry in chronic kidney disease
Levente Babos1, Zoltán Járai, János Nemcsik
1Levente Babos, János Nemcsik, Department of Family Medicine, Semmelweis University, 1125 Budapest, Hungary.
Insights
Early diagnosis of endothelial dysfunction (ED) in chronic kidney disease (CKD) is crucial for managing cardiovascular disease mortality. Laser Doppler flowmetry (LDF) offers a non-invasive method to assess microcirculation and ED in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular diseases are a leading cause of mortality in chronic kidney disease (CKD) patients.
- Accelerated atherosclerosis and endothelial dysfunction (ED) are key contributors to this mortality.
- Early detection of ED is vital for timely interventions and improved patient outcomes.
Purpose of the Study:
- To review diagnostic methodologies for endothelial dysfunction (ED) in chronic kidney disease (CKD).
- To focus on Laser Doppler flowmetry (LDF) based tests for ED assessment.
- To summarize current data on LDF applications in CKD patients for clinical utility.
Main Methods:
- Review of various Laser Doppler flowmetry (LDF) tests for endothelial dysfunction (ED) diagnosis.
- Specific LDF methods discussed include postocclusive reactive hyperemia, local heating, iontophoresis, microdialysis, and flowmotion analysis.
- Synthesis of existing research data on LDF in chronic kidney disease (CKD) populations.
Main Results:
- Laser Doppler flowmetry (LDF) provides continuous, non-invasive microcirculation monitoring.
- Various LDF-based tests have been developed for assessing endothelial dysfunction (ED).
- Data on LDF application in chronic kidney disease (CKD) patients requires further summarization for clinical relevance.
Conclusions:
- Endothelial dysfunction (ED) is an early event in the accelerated atherosclerosis of chronic kidney disease (CKD).
- Laser Doppler flowmetry (LDF) offers promising non-invasive techniques for ED diagnosis in CKD.
- Further research and data synthesis are needed to establish LDF's clinical role in managing CKD patients.
Abstract:
Cardiovascular diseases are the major causes of mortality in patients with chronic kidney disease (CKD). The complex process of accelerated athero- and arteriosclerosis in CKD is associated with this phenomenon, where endothelial dysfunction (ED) is one of the initial steps. Hence, the early diagnosis of ED can potentially lead to early interventions which could result in a better outcome for these patients. Several methodologies have been developed for the diagnosis of ED. Laser Doppler flowmetry (LDF) enables us to study the microcirculation continuously in a non-invasive manner. In our review we would like to focus on different tests developed for LDF, like postocclusive reactive hyperaemia, local heating, iontophoresis, microdialysis or analysis of flowmotion. We would also like to summarize the available data in CKD with these methodologies to enlighten their perspectives in the clinical use on this patient population.
Related Concept Videos
Diabetic Nephropathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management

